Prevalence and economic burden of major comorbidities in multiple sclerosis
ConclusionsOur study provides evidence of the burden of comorbidities in MS. Comorbidity is common in MS and produce additive costs.Key messagesThe use of administrative data for tracking the MS comorbidity could help knowledge gaps.When additivity situation is involved, preventive policies could lead to monetary savings.
Source: The European Journal of Public Health - Category: General Medicine Source Type: research
More News: Anxiety | Autoimmune Disease | Cancer | Cancer & Oncology | Cardiology | Chronic Leukemia | Depression | Diabetes | Diabetic Ulcers | Endocrinology | Gastric (Stomach) Cancer | Gastric Ulcer | Gastroenterology | General Medicine | Healthcare Costs | Heart | Heart Disease | HIV AIDS | Hypertension | International Medicine & Public Health | Ischemic Stroke | Italy Health | Leukemia | Lymphoma | Multiple Sclerosis | Renal Failure | Stroke | Study